ProPharma Group Acquires The Weinberg Group
January 28, 2019
ProPharma Group, a portfolio company of Linden Capital Partners, has acquired The Weinberg Group, a Washington, D.C.-based regulatory and compliance consultancy serving the pharmaceutical, biotech, and medical device industries. The deal expands ProPharma's pre-approval and pre-clinical regulatory capabilities and further integrates Weinberg's FDA-focused regulatory expertise into ProPharma's global life sciences compliance platform.
- Targets
- The Weinberg Group Inc.
- Platforms
- ProPharma Group
- Industry
- Healthcare Services
- Location
- District of Columbia, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
ProPharma Group Acquires OneSource Regulatory and OneSource Regulatory Technology
August 23, 2022
Healthcare Services
ProPharma Group, a PE-backed provider of regulatory, clinical and compliance services, has acquired OneSource Regulatory and OneSource Regulatory Technology to expand its regulatory, medical and marketing operations services and technology capabilities. The deal brings OneSource’s regulatory consulting and promotional/labeling review expertise (headquartered in McKinney, Texas) into ProPharma’s global life sciences services platform; Edgemont Partners acted as exclusive financial advisor to OneSource.
-
ProPharma Group Acquires Pharmica Consulting
October 6, 2021
Healthcare Services
ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Pharmica Consulting, a life‑science consulting firm offering project management services and proprietary operations software for clinical trials. The acquisition expands ProPharma’s clinical and project‑management capabilities and enables Pharmica’s cloud‑based tools to be offered more broadly across ProPharma’s global client base.
-
ProPharma Group Acquires Diamond Pharma Services
March 2, 2021
Healthcare Services
ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Diamond Pharma Services, a UK-based regulatory affairs, pharmacovigilance, and compliance consultancy. The deal expands ProPharma's global regulatory and pharmacovigilance capabilities and adds Diamond's ~85+ experts and UK footprint to ProPharma's existing suite of services.
-
Odyssey Investment Partners Acquires ProPharma Group
September 22, 2020
Healthcare Services
Odyssey Investment Partners has agreed to acquire ProPharma Group from Linden Capital Partners. ProPharma Group, a global provider of regulatory, compliance, pharmacovigilance and medical information services headquartered in Overland Park, Kansas, will be led by CEO Dawn Sherman and the existing management team who are reinvesting alongside Odyssey to pursue organic and inorganic growth.
-
ProPharma Group (Linden Capital Portfolio) Acquires Southwood Research
March 11, 2019
Healthcare Services
ProPharma Group, a portfolio company of Linden Capital Partners, has acquired Southwood Research, a Buckinghamshire-based provider of pre-approval regulatory science services to the pharmaceutical and biotech industries. The add-on expands ProPharma's regulatory affairs capabilities across the EU and strengthens its end-to-end regulatory service offering.
-
Genpact Acquires Pharmalink Consulting
April 23, 2014
Healthcare Services
Genpact Ltd. signed a definitive agreement to acquire Pharmalink Consulting, a provider of regulatory affairs services to the life sciences industry, and completed the transaction in May 2014. The acquisition expands Genpact's life sciences capabilities—adding regulatory strategy, CMC, regulatory operations and publishing services—and brings Pharmalink employees in the US, UK, India, Ireland and Puerto Rico into Genpact's Life Sciences vertical.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.